Overall, our work unveils a role for DHH in heightened tumor angiogenesis and permeability, which may ultimately favor GBM progression, and thus places the DHH/Ptch2 nexus as a putative target for novel therapies directed against malignant stem-cell niches in GBM. This evidence concerns the gene DHH and neoplasm.